The Tissue Core will collect tissue from subjects in Project 1 and distribute it to Projects 2 and 3. Specifically: Brains of Project 1 rats (Dr. Roberts) that self-administer cocaine under the DT4 schedule, with and without exposure to candidate medications, will be hemisected and distributed to Project 2 for analysis of immediate early gene expression (Dr. Porrino) and tissue neurotransmitter content (Dr. Jones). Brains of Project 1 rats (Dr. Roberts) that self-administer cocaine under the progressive-ratio schedule, with and without exposure to candidate medications, will be hemisected and distributed to Project 3 for analysis of receptor binding and G-protein receptor function (Dr. Childers) and signal transduction systems (Dr. Howlett). Brains of monkeys that self-administer cocaine under the progressive-ratio schedule in Project 1 (Dr. Nader) will be hemisected and distributed as follows: ? one hemisphere will be distributed to Project 2 for in vitro receptor autoradiography (Dr. Porrino) and tissue neurotransmitter content (Dr. Jones). ? the other hemisphere will be distributed to Project 3 for identification of candidate genes and proteins via laser capture dissection (Dr. Hemby). In later years of the Center, these experiments will include synaptosomal preparations. In addition to distributing tissue from Project 1, the Tissue Core will treat separate groups of rats with drugs found to demonstrate efficacy in reducing self-administration rats in Project 1. Brains from these rats will be distributed to Project 3 for assessment of G-protein receptor function (Dr. Childers) and changes in signal transduction systems (Dr. Howlett). In addition to brain tissue, cerebrospinal fluid and venous blood will be periodically collected from nonhuman primates in Project 1 and stored for future use by investigators within and outside the Center. Several additional tissues will be collected at necropsy, including the pituitary gland, heart, myocardium, pancreatic tail, Kver lobe and adrenal glands. This list can be expanded based on future research questions and collaborations within and outside the Center.
The Tissue Core will play an integral role in collecting, storing and organizing tissue samples form animals used in the Center's behavioral experiments and making sure those are distributed to investigatiors performing imaging and biochemical experiments.
|Fetterhoff, Dustin; Opris, Ioan; Simpson, Sean L et al. (2015) Multifractal analysis of information processing in hippocampal neural ensembles during working memory under ??-tetrahydrocannabinol administration. J Neurosci Methods 244:136-53|
|Siciliano, Cody A; Calipari, Erin S; Ferris, Mark J et al. (2014) Biphasic mechanisms of amphetamine action at the dopamine terminal. J Neurosci 34:5575-82|
|Smith, Hilary R; Beveridge, Thomas J R; Nader, Michael A et al. (2014) Regionally-specific alterations in myelin proteins in nonhuman primate white matter following prolonged cocaine self-administration. Drug Alcohol Depend 137:143-7|
|Pattison, Lindsey P; McIntosh, Scot; Sexton, Tammy et al. (2014) Changes in dopamine transporter binding in nucleus accumbens following chronic self-administration cocaine: heroin combinations. Synapse 68:437-44|
|Siciliano, Cody A; Calipari, Erin S; Jones, Sara R (2014) Amphetamine potency varies with dopamine uptake rate across striatal subregions. J Neurochem 131:348-55|
|Beveridge, Thomas J R; Smith, Hilary R; Nader, Susan H et al. (2014) Functional consequences of cocaine re-exposure after discontinuation of cocaine availability. Neuropharmacology 85:528-37|
|Ferris, Mark J; España, Rodrigo A; Locke, Jason L et al. (2014) Dopamine transporters govern diurnal variation in extracellular dopamine tone. Proc Natl Acad Sci U S A 111:E2751-9|
|Gill, Kathryn E; Chappell, Ann M; Beveridge, Thomas J R et al. (2014) Chronic methylphenidate treatment during early life is associated with greater ethanol intake in socially isolated rats. Alcohol Clin Exp Res 38:2260-8|
|Nader, Michael A; Banks, Matthew L (2014) Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimaging. Neuropharmacology 76 Pt B:510-7|
|Bough, Kristopher J; Amur, Shashi; Lao, Guifang et al. (2014) Biomarkers for the development of new medications for cocaine dependence. Neuropsychopharmacology 39:202-19|
Showing the most recent 10 out of 233 publications